Your session is about to expire
← Back to Search
Behavioural Intervention
Exercise Group for Head and Neck Cancers (LIFTING2 Trial)
Phase 2
Waitlist Available
Led By Kerry Courneya
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, postintervention (12 weeks), and monitored throughout 12 week study period
Awards & highlights
LIFTING2 Trial Summary
"This trial will examine whether heavy lifting strength training can help improve side effects in head and neck cancer survivors, such as loss of muscle strength and fatigue, which impact their quality of life and ability to return
Who is the study for?
This trial is for head and neck cancer survivors who have finished their treatment. It's designed to see if heavy lifting strength training can help with muscle strength, physical function, fatigue, and swallowing issues that affect life quality.Check my eligibility
What is being tested?
The LIFTING 2 trial is testing the benefits of a heavy lifting strength training program compared to no exercise at all in people who've survived head and neck cancer. The goal is to improve their muscular strength and overall well-being.See study design
What are the potential side effects?
Since this study involves physical exercise, potential side effects may include muscle soreness or injury. However, these are generally mild and manageable with proper supervision.
LIFTING2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, postintervention (12 weeks), and monitored throughout 12 week study period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, postintervention (12 weeks), and monitored throughout 12 week study period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence to a heavy lifting strength training program
Completion of maximal strength testing
Followup assessment rate
+2 moreSecondary outcome measures
Body composition
Cancer Specific Quality of Life
Fear of Cancer Recurrence
+10 moreLIFTING2 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise GroupExperimental Treatment1 Intervention
The exercise intervention will consist of 24 supervised, heavy lifting strength training exercise sessions over a 12 week period. The exercise frequency will be two times per week. Main exercises will consist of barbell back squat, bench press, and dead lift.
Group II: Usual Care GroupActive Control1 Intervention
Participants randomized to the usual care group will be asked to continue will their typical daily routine during the 12 week study period, and not begin any new exercise program to increase their exercise levels from baseline. They will not receive any information or education regarding exercise. After the postintervention assessments, participants in the usual care group will be offered a 4-week introduction to heavy lifting strength training program and/or referred to a community-based exercise program
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,117 Total Patients Enrolled
Kerry CourneyaPrincipal InvestigatorUniversity of Alberta
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the potential risks of participating in a group exercise program for individuals with medical conditions?
"Given the preliminary nature of this trial, our team at Power rates the safety of the Exercise Group as a 2 on our scale. This indicates that while there is some existing data supporting safety, there is currently no evidence supporting efficacy."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger